ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1047

Infrared Thermography Imaging Discriminates Between Inflamed and Non-inflamed Joints

Maria I. ("Maio") Danila1, Giovanna Rosas2, Fenglong Xie2, Jeffrey R Curtis3, Kiara Aaron2, Stephanie Ford2 and Laura Hughes4, 1University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, AL, 4University of Alabama at Birmingham; East Alabama Medical Center, Birmingham, AL

Meeting: ACR Convergence 2023

Keywords: Disease Activity, Imaging, Osteoarthritis, rheumatoid arthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1033–1051) Imaging of Rheumatic Diseases Poster I

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Infrared thermography (IRT) is an emerging technology that has the potential to rapidly assist in identifying joint inflammation in patients with joint symptoms. However, its use in clinical practice is currently limited due to the lack of a true gold standard (e.g., musculoskeletal ultrasound [MSUS]) confirming the presence of joint inflammation. We aimed to determine whether there are differences in IRT measurements between joints categorized as inflamed or not based on Power Doppler (PD) ultrasound imaging.

Methods: We conducted a cross sectional study among patients at a tertiary academic medical center. Eligible patients were age ≥ 18 years, had a rheumatologist-diagnosis of rheumatoid arthritis or a non-inflammatory joint condition (e.g. osteoarthritis) or healthy controls, and had at least one swollen joint in the hands or wrists or feet (RA patients only). IRT images were obtained using a FLIR E75 3400 camera. A manual segmentation approach was employed to place rectangular regions of interests (ROIs) over each of the 32 target joint sites. FLIR software was used to determine IRT temperature (0C) parameters including ROI maximum (max), minimum (min), mean (mean), center (center) and within joint variability (STD). MSUS was obtained at the same visit by a rheumatologist with RhMSUS certification. MSKUS erosions (presence/absence), joint inflammation (PD) and synovial hypertrophy (SHT) was scored using a 0-3 severity scale (none =0, mild =1, moderate=2, and severe =3) for each wrist, metacarpophalangeal (MCP), proximal interphalangeal (PIP) and metatarsophalangeal (MTP) joint. We used mixed effects logistic regression to determine whether IRT parameters were able to discriminate between inflamed (i.e. PD score ≥ 1) and not inflamed joints (PD=0), accounting for clustering of joints within patients and adjusting for demographic factors including age, sex, and race.

Results: A total of 50 patients with RA (n=30), OA (n=10), healthy controls mean (SD) age 54.8 (14.20) years, mostly women (90.0%), 22 (44%) Black participated in the study. A total of 1598 joints were included in the analysis including 103 joints with a PD ≥ 1. A total of 248 joints had erosions. IRT measurements by PD score are presented in the Table. The c-statistic for the area under the receiver operator curve was 0.82 (Figure). After multivariable adjustment, the minimum, maximum and the within-joint variability (STD) of the thermography camera temperature readings were significantly associated with joint inflammation compared to the gold standard of PD={1,2} by MSUS. Older age, female sex, and black race also were significantly associated with the outcome.

Conclusion: We found that a commercially-available infrared thermography camera had reasonable accuracy to discriminate between inflamed versus non-inflamed joints among people with RA, OA, and healthy controls. These findings can help inform future use of IRT in clinical practice to discriminate between inflammatory and non-inflammatory joint disease in settings where a rheumatologist physical exam may not be feasible.

Supporting image 1

Table: Infrared thermography measurements by Power Doppler (PD) score.

Supporting image 2

Figure: Receiver Operator Curve comparing thermography with musculoskeletal ultrasound for classifying joint inflammation (PD = 1 or 2)


Disclosures: M. Danila: Horizon, 5, Pfizer, 5, RheumNow, 2, UCB, 2; G. Rosas: None; F. Xie: None; J. Curtis: AbbVie, 2, 5, Amgen, 2, 5, BMS, 2, 5, Corrona, 2, 5, Crescendo, 2, 5, Genentech, 2, 5, Janssen, 2, 5, Pfizer, 2, 5, Roche, 2, 5, UCB Pharma, 2, 5; K. Aaron: None; S. Ford: None; L. Hughes: None.

To cite this abstract in AMA style:

Danila M, Rosas G, Xie F, Curtis J, Aaron K, Ford S, Hughes L. Infrared Thermography Imaging Discriminates Between Inflamed and Non-inflamed Joints [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/infrared-thermography-imaging-discriminates-between-inflamed-and-non-inflamed-joints/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/infrared-thermography-imaging-discriminates-between-inflamed-and-non-inflamed-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology